|
RGS4: A New Target for PD Therapy? Dysregulation of striatal plasticity contributes to the pathology of Parkinson's disease. Anatol Kreitzer and colleagues identify RGS4 as a key regulator of ... Contributed by: David Simmons
|
|---|
RGS4: A New Target for PD Therapy? Dysregulation of striatal plasticity contributes to the pathology of Parkinson's disease. Anatol Kreitzer and colleagues identify RGS4 as a key regulator of ...
Contributed by: David Simmons
Share video with friends:
Report Broken Video